2nd Quarter - Amendment

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,530,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Amendment (this page) Jul 19, 2013 $1,530,000 Replaced
2nd Quarter - Amendment Mar 21, 2014 $1,560,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
CAROLINE MOODY SCHELLHAS —
MARY BRIDGET WALSH —

Contacted: Executive Office of the President (EOP); Patent & Trademark Office (PTO); State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2735 (113th)

Health Issues HCR

Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); State, Dept of (DOS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC)

Consumer Issues/Safety/Products CSP

Certified Importer Program Supply Chain Issues

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Copyright/Patent/Trademark CPT

Patent Settlements Patent Reform Patent Troll Legislation

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Executive Office of the President (EOP); Patent & Trademark Office (PTO); SENATE; Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations India IP/Trade Issues

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
CLAUDIA POTEET New Senate Finance Committee Professional Staff
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Alcohol and Drug Abuse ALC

Opioid Abuse Prescription Drug Abuse

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); State, Dept of (DOS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.